Last data update:
28 October 2020 04:16 CET
| New search |
| Strain number: | IHEM 3731 Add to cart |
| Species name: | Candida albicans (Robin) Berkhout |
| Synonym names: | Candida africana H.-J. Tietz, Hopp, Schmalreck, Sterry & Czaika Candida claussenii Lodder & Kreger-van Rij Candida langeronii Dietrichson ex van Uden & Buckley Candida nouvelii Saëz Candida stellatoidea (C.P. Jones & Martin) Langeron & Guerra Candida truncata Vanbreuseghem Endomyces albicans (Robin) Vuillemin Monilia albicans (C.P. Robin) Zopf Oidium albicans C.P. Robin Syringospora albicans (Robin) Dodge Syringospora claussenii van der Walt Syringospora stellatoidea van der Walt |
| Type of organism: | Yeast |
| Pathogen class: | H2 |
| Acronyms: | ATCC 10231, B 49904, CBS 6431, DSM 1386, IFO 1594, MUCL 30114, NCPF 3179, NCYC 1363, NIH 3147, VTT C-85161 |
| Original substratum: | human |
| Pathogenicity (underlying disease): | bronchomycosis |
| History: | Wright -> C.W. Emmons -> NIH -> ATCC -> B -> 1988, IHEM |
| Applications: | growth and invasiveness in mouse (Appl. Microbiol. 14: 737-741, 1966); steroid interference with antifungal activity (ibid., 14: 865-869, 1966); ultraviolet microscopy (J. Bacteriol. 92: 1812-1820, 1966); calcification (ibid., 122: 1391-1393, 1975); morphology and physiology of strain sectors (Mycopathol. Mycol. Appl. 34: 209-220, 1968); assay of haloprogin, amphotericin B and nystatin (Can. J. Microbiol. 20: 1241-1245, 1974); sterility testing (J. Pharm. Sci. 60: 1087-1088, 1971; U.S. Pharmacopeia, 22nd ed., pp. 1483-1488, 1990); assay of antimicrobial preservatives (ibid., pp.1478-1479,1990 ; ANSI/ ASTM E 640-78; Br. Pharmacopeia,v. 2, pp. A200-A203, 1988); media testing (ibid.,v. 2, pp. A197-A200, 1988); use of impedance for preservative efficacy testing (J. Appl. Bacteriol. 76: 68-74, 1994); fungitoxicity of alcohols and fatty acids (J. Pharm. Sci. 69: 381-384, 1980); esterase activity (J. Clin. Microbiol. 8: 756-759, 1978); lipid composition (Dev. Ind. Microbiol. 21: 373-378, 1980); produces: autoantibiotics phenethyl alcohol and tryptophol (Science (Washington, DC) 163: 192-194, 1969), estrogen-binding protein (Endocrinology 124: 1965-1972, 1989), extracellular aspartyl proteinase (J. Gen. Microbiol. 139: 1643-1651, 1993) and DNA topoisomerase (Antimicrob. Agents Chemother. 36: 2778-2784, 1992); effect of antineoplastic drugs (Mykosen 27: 452-464, 1984); sequence of INO1 gene, GenBank / EMBL L22737 (Yeast 10: 789-800, 1994) |
| Literature: |
Denis O, Van Cauwenberge A, Treutens G, Es Saadi B, Symoens F, Popovic N, Huygen K., Mycopathologia 173 (2012), 151-162 [DOI: 10.1007/s11046-011-9466] |
| New search |